Wyer PC, Keitz S, Hatala R, et al. Tips for learning and teaching evidence-based medicine: introduction to the series. CMAJ 2004;171:347-8

Barratt A, Wyer PC, Hatala R, et al. 1. Relative risk reduction, absolute risk reduction and number needed to treat. CMAJ 2004;171:353-8

Montori VM, Kleinbart J, Newman TB, et al. 2. Measures of precision (confidence intervals). CMAJ 2004;171:611-5

McGinn T, Wyer PC, Newman TB, et al. 3. Measures of observer variability (kappa statistic). CMAJ 2004;171:1369-73

Hatala R, Keitz S, Wyer P et al. Tips for learners of evidence-based medicine: 4. Assessing heterogeneity of primary studies in systematic reviews and whether to combine their results. CMAJ 2005;172:661-5

Montori VM, Wyer P, Newman TB, et al. 5. The effect of spectrum of disease on the performance of diagnostic tests. CMAJ 2005;173:385-90

Cullum N. Users' guides to the nursing literature: an introduction. Evid Based Nurs 2000;3:71-2

Cullum N. Evaluation of studies of treatment or prevention interventions. Evid Based Nurs 2000;3:100-102

Cullum N. Evaluation of studies of treatment or prevention interventions. Part 2: applying the results of studies to your patients. Evid Based Nurs 2001;4: 7-8

Ciliska D, Cullum N, Marks S. Evaluation of systematic reviews of treatment or prevention interventions. Evid Based Nurs 2001;4:100-104

Jull A. Evaluation of studies of assessment and screening tools, and diagnostic tests. Evid Based Nurs 2002;5 68-72

Stone PW, Bakken S, Curran CR, Walker PH. Evaluation of studies of health economics  Evid Based Nurs 2002;5:100-104

Russell CK, Gregory DM. Evaluation of qualitative research studies. Evid Based Nurs 2003;6:36-40

Fineout-Overholt E, Melnyk BM. Evaluation of studies of prognosis. Evid Based Nurs 2004;7:4-8

Adamson J. Evaluation of studies of causation (aetiology). Evid Based Nurs 2004;7:36-40

Greenhalg T. The Medline database. BMJ 1997,315:180-183

Greenhalg T.  Getting your bearings (deciding what the paper is about). BMJ 1997;315:243-246

Greenhalg T. Assessing the methodological quality of published papers. BMJ 1997;315:305-308

Greenhalg T. Statistics for the non-statistician. 1: different types of data need different statistical tests. BMJ 1997;315:364-366

Greenhalg T. Statistics for the non-statistician. 2: "significant" relations and their pitfalls. BMJ 1997;315:422-425

Greenhalg T. Papers that report drug trials. BMJ 1997;315:480-483

Greenhalg T. Papers that report diagnostic or screening tests. BMJ 1997;315:540-543

Greenhalg T. Papers that tell you what things cost (economic analyses). BMJ 1997;315: 596-599

Greenhalg T. Papers that summarise other papers (systematic reviews and meta- analyses). BMJ 1997;315: 672-675

Greenhalg T. Papers that go beyond numbers (qualitative research).  BMJ 1997;315:740-743

I. Why try to keep and how to get started. Ann Intern Med 1986;105:149-53 [abstract]

II. Deciding which journals to read regularly. Ann Intern Med 1986;105:309-12 [abstract]

III. Expanding the number of journal you read regularly. Ann Intern Med 1986;105:474-8 [abstract]

IV. Using the literature to solve clinical problems Ann Intern Med 1986;105:636-40 [abstract]

V. Access by personal computer to the medical literature. Ann Intern Med 1986;105:810-24 [abstract]

VI. How to store and retrieve articles worth keeping. Ann Intern Med 1986;105:978-84 [abstract]

I. Why to read them and how to start reading them critically. Can Med Assoc J 1981;124:555-8

II. To learn about a diagnostic test. Can Med Assoc J 1981;124:703-10

III. To learn the clinical course and prognosis of disease. Can Med Assoc J 1981;124:869-72

IV. To determine etiology or causation. Can Med Assoc J 1981;124:985-90

V. To distinguish useful from useless or even harmful therapy. Can Med Assoc J 1981;124:1156-62

VI. To learn about the quality of clinical care. Can Med Assoc J 1984;130:377-81

VII A. To understand an economic evaluation (part A). Can Med Assoc J 1984;130:1428-34

VII B. To understand an economic evaluation (part B). Can Med Assoc J 1984;130:1542-49

IX. Sounding like you've read the literature when you haven't read a thing. CMAJ 1998;159:1488-9

X. How to react when your colleagues haven't read a thing. CMAJ 2000;163:1570-2

XI. Everything you always wanted to know about editorials (but were afraid to ask). CMAJ 2003 169:1323-1325

XII. How you too can profit from pharmaceutical advertisements. CMAJ 2004;171:1455-6